Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Market Value Is The Human Immunodeficiency Virus (HIV) Diagnosis Industry Expected To Reach By 2029, Starting From 2025 Levels?
The market for human immunodeficiency virus (hiv) diagnosis has experienced significant expansion recently. Projections indicate its expansion from $4.2 billion in 2024 to $4.67 billion in 2025, showing a compound annual growth rate (CAGR) of 11.2%. Historically, this growth can be ascribed to several factors, including the increased availability of voluntary counseling and testing, the creation of HIV antibody tests, the onset of the HIV/AIDS epidemic, and various community-driven and peer-supported programs.
The market for human immunodeficiency virus (HIV) diagnosis is projected to experience swift expansion over the coming years. This market is forecast to reach $6.88 billion by 2029, achieving a compound annual growth rate (CAGR) of 10.1%. Factors contributing to this growth during the projection period include public health campaigns and awareness programs, a heightened focus on equity and inclusivity, the integration of routine testing in healthcare environments, community and peer-driven strategies, and the wider availability of self-testing options. Key trends anticipated during the forecast period encompass progress in testing technologies, a concentrated effort on targeted testing methods, expanding community-based testing and outreach programs, a continued emphasis on equity and inclusivity, and evolving policy and funding directions.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15587&type=smp
What Are The Top Growth Drivers Impacting The Human Immunodeficiency Virus (HIV) Diagnosis Market Outlook?
The anticipated expansion of the HIV diagnosis market is significantly influenced by the growing trend of blood donation. Blood donation involves individuals voluntarily contributing blood, typically via phlebotomy, where a needle collects blood from a vein. This upsurge in donations stems from enhancements in medical technology, greater community participation, and more effective strategies for donor recruitment and retention. An increase in blood donors results in a larger pool of samples readily available for HIV testing. This heightened availability of blood specimens facilitates more thorough screening for HIV antibodies or antigens, thereby improving the precision and reliability of HIV diagnosis. A notable illustration of this is how NHS Blood and Transplant, a UK-based government agency, recorded an increase in new blood donors from 119,016 in 2022-2023 to 119,371 in 2023-2024. Consequently, the rising rate of blood donation acts as a key driver for the growth within the HIV diagnosis market.
What Are The Leading Segments Analyzed In The Human Immunodeficiency Virus (HIV) Diagnosis Market?
The human immunodeficiency virus (hiv) diagnosismarket covered in this report is segmented –
1) By Product: Consumables; Instruments; Software And Services
2) By Mode: Self-Test; Lab-Based
3) By End User: Diagnostic Laboratories; Hospitals; Research Institutions
Subsegments:
1) By Consumables: Test Kits (Rapid Hiv Test Kits, Elisa Test Kits); Reagents And Chemicals; Sample Collection Devices (Blood Collection Tubes, Lancets); Test Strips; Control And Calibration Kits; Disposable Gloves And Safety Equipment
2) By Instruments: Hiv Diagnostic Analyzers ( Automated Immunoassay Analyzers); Hiv Viral Load Testing Equipment; Cd4 Count Analyzers; Point-Of-Care Hiv Diagnostic Devices; Molecular Diagnostic Instruments ( Pcr Machines); Electrochemical And Optical Hiv Detection Instruments
3) By Software: Hiv Diagnosis Data Management Software; Electronic Health Record (Ehr) Integration Software; Hiv Test Result Interpretation Software; Laboratory Information Management Systems (Lims); Patient Monitoring And Tracking Software; Cloud-Based Hiv Diagnostic Reporting Tools
4) By Services: Diagnostic Testing Services; Hiv Testing Support Services ( Counseling, Education); Diagnostic Lab Services; Telemedicine And Remote Hiv Testing Services; Clinical Trial Services For Hiv Diagnostic Tests; Data Analytics And Interpretation Services For Hiv Testing
How Are Trends Influencing The Human Immunodeficiency Virus (HIV) Diagnosis Market?
Leading firms within the HIV diagnosis market are focusing on creating chip-based real-time PCR test solutions specifically for HIV, aiming to boost precision, shorten processing periods, and broaden access. These chip-based real-time PCR tests for HIV represent diagnostic instruments employing microfluidic chips or compact integrated circuits to perform real-time polymerase chain reaction (PCR) tests for HIV detection. An illustration of this is Molbio Diagnostics, an India-based molecular diagnostics manufacturer, which introduced the Truenat HIV-1 test in August 2022. This particular test is a chip-based real-time PCR solution designed for the quantitative detection and diagnosis of human immunodeficiency virus type 1 (HIV-1) in samples of whole blood and plasma. Its purpose is to assist in tracking the HIV-1 viral load in individuals afflicted with HIV-1 infection. Utilizing Taqman chemistry, the test boasts high primer sensitivity and specificity. It necessitates a mere 6 mcL sample volume and incorporates an intelligent chip containing lot-specific data for result quantification. The design also features a chip re-use lock and a reaction port engineered to resist contamination and evaporation.
Which Key Players Are Driving Competition In The Human Immunodeficiency Virus (HIV) Diagnosis Market?
Major companies operating in the human immunodeficiency virus (HIV) diagnosis market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Becton Dickinson and Company, Hologic Inc., bioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corporation, Alere Inc., Cepheid Inc., OraSure Technologies Inc., Advanced Instruments Inc., BBI Solutions, Chembio Diagnostic Systems Inc., BioLytical Laboratories Inc., Avioq Inc., Advanced Biochemicals Ltd., Advanced Molecular Diagnostics, Atila BioSystems Inc., BioAssay Works LLC, Chemtron Biotech Inc.
Download The Full Report For Exclusive Market Findings:
Which Geographies Are Emerging As Strong Markets For The Human Immunodeficiency Virus (HIV) Diagnosis Industry?
North America was the largest region in the HIV diagnosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human immunodeficiency virus (HIV) diagnosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Human Immunodeficiency Virus (HIV) Diagnosis Market Report:
https://www.thebusinessresearchcompany.com/customise?id=15587&type=smp
Browse Through More Reports Similar to the Global Human Immunodeficiency Virus (HIV) Diagnosis Market 2025, By The Business Research Company
Immunohistochemistry Ihc Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/immunohistochemistry-ihc-global-market-report
Immunohematology Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report
Immunoglobulins Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model